Logo image
Phytochemical profiling and therapeutic potential of lemon-scented tea tree (Leptospermum petersonii)
Journal article   Open access   Peer reviewed

Phytochemical profiling and therapeutic potential of lemon-scented tea tree (Leptospermum petersonii)

Phuong Lan Hoang, Trong Duc Tran, Jayne Gilbert, Jennette Sakoff, Christopher J. Scarlett and Quan Van Vuong
Biocatalysis and Agricultural Biotechnology, Vol.74, pp.1-13
2026
pdf
1-s2.0-S1878818126001520-main2.30 MBDownloadView
Published Version Open Access CC BY V4.0
url
https://doi.org/10.1016/j.bcab.2026.104069View
Published Version Open CC BY V4.0

Abstract

anti-Alzheimer's disease Anti-diabetic Anti-Pancreatic cancer LC-QTOF MS Phenolic compound profile
Lemon-scented tea tree (Leptospermum petersonii, Myrtaceae family) has been traditionally used as both bush food and medicine by Australian Aboriginal people. However, its key individual phytochemicals and therapeutic potential are not well characterised. The study investigated major phytochemicals and evaluated the anti-diabetic, anti-Alzheimer's, and anti-pancreatic cancer potential of L. petersonii extract and its fractions. The fraction was carried out based on the retention time by using HPLC. Major phytochemicals were identified using LC-QTOF-MS and HPLC. Total phenolic content and antioxidant activity were determined using Folin-Ciocalteu, DPPH, ABTS, and FRAP assays. In vitro assays, including α-glucosidase, α-amylase, acetylcholinesterase inhibition, and MTT cytotoxicity tests, were used to assess anti-diabetic, anti-Alzheimer's, and anti-pancreatic cancer potential, respectively. As a result, six phenolic acids, ten flavonoids, two phenols, and four triterpenoids were identified. The crude extract showed high phenolic content (96 mg GAE/g DW), abundant terpenoids (302 mg EE/g DW), and strong antioxidant activity. Fractionation of the crude extract produced four fractions with significantly enhanced bioactive properties. Fraction 1 (F1) exhibited the highest phenolic content and antioxidant capacity, and over 3-fold stronger α-glucosidase inhibition compared to the crude extract. Fraction 3 (F3) showed 10-fold greater acetylcholinesterase inhibition, while Fraction 4 (F4) demonstrated a 20-fold stronger inhibitory effect on pancreatic cancer cell growth, including AsPC-1, BxPC-3, Capan-2, HPAC, MiaPaCa2, PANC-1 (p < 0.05). These findings highlight L. petersonii as a promising source of bioactive compounds with potential therapeutic applications.

Details

Metrics

1 Record Views
Logo image